Home » Topics » BioWorld Science

BioWorld Science
RSS

WAY-812: a potent, long-acting 5-HT1A antagonist identified at Wyeth-Ayerst

Nov. 13, 2001

Phase I findings support advancement of CI-1023 to phase II evaluation

Nov. 13, 2001

Lipophilic metal chelator representative of new class of therapies for neurodegenerative disorders

Nov. 13, 2001

SOD mimetic protects cardiac allografts from ischemia-reperfusion injury

Nov. 13, 2001

Motilin antagonists identified at Ortho-McNeil

Nov. 12, 2001

Wilex and Max Planck design new selective uPA inhibitors for cancer therapy

Nov. 12, 2001

Subunit-selective GABA-A receptor agonists in development by Sanofi-Synthelabo

Nov. 12, 2001

New series of cell adhesion inhibitors and potential uses described by Novartis

Nov. 12, 2001

New imidazoles for histamine H3-mediated disorders jointly identified by European labs

Nov. 12, 2001

Sulfonamide glutamate receptor potentiators useful in cognitive impairment

Nov. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...